ClinicalTrials.gg
CompletedNCT05739318Updated May 1, 2024

the Diameter of Double-lumen Tube Measured by Different Methods

An interventional study of The cuff of endotracheal and endobronchial is collapsed and The cuff of endotracheal and endobronchial is inflated in Therapeutic Procedural Complication, sponsored by The First Hospital of Qinhuangdao. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-05-01.

Sponsored by The First Hospital of Qinhuangdao · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The comparison of the diameter of double-lumen tube at the cuff of endotracheal and endobronchial during the cuff was collapse or inflated as a guide for the selection of the size of double-lumen tube.

Read the detailed description

The comparison of the diameter of double-lumen tube at the cuff of endotracheal and endobronchial during the cuff was collapse or inflated as a guide for the selection of the size of double-lumen tube.

02

Conditions studied

  • Therapeutic Procedural Complication
03

In context

Lead sponsor

The First Hospital of Qinhuangdao is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

less than 35 kg/m2 ASA classifications of I-III, Modified Mallampati classification 1 or 2 Under general anesthesia

Exclusion criteria

Exclusion Criteria:

Age younger than 18 yr or older than 70 yr

  • IV or V
  • Abnormalities of the heart, brain, liver, lung, kidney and coagulation function
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    The cuff of endotracheal and endobronchial is collapsed

    The diameter of double-lumen tube at the cuff of endotracheal and endobronchial during the cuff is collapsed

    Device: The cuff of endotracheal and endobronchial is collapsed

  • Experimental
    The cuff of endotracheal and endobronchial is inflated

    The diameter of double-lumen tube at the cuff of endotracheal and endobronchial during the cuff is inflated

    Device: The cuff of endotracheal and endobronchial is inflated

Interventions

  • DeviceThe cuff of endotracheal and endobronchial is collapsed

    The diameter of double-lumen tube at the cuff of endotracheal and endobronchial when the cuff is collapsed as the diameter of double-lumen tube and select a double-lumen tube that matches the patient's trachea and bronchial innerdiameter based on this diameter

  • DeviceThe cuff of endotracheal and endobronchial is inflated

    The diameter of double-lumen tube at the cuff of endotracheal and endobronchial when the cuff is inflated as the diameter of double-lumen tube and select a double-lumen tube that matches the patient's trachea and bronchial innerdiameter based on this diameter

06

What researchers measure

Primary outcomes

  1. Incidence of complications

    Incidence of postoperative hoarseness and throat pain in patients

    Time frame: 12 weeks

07

Study locations

1 site
  • The first hospital of Qinhuangdao
    Qinhuangdao, Hebei 066000, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2023 to primary completion in Jul 2023, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2023
First posted
Feb 22, 2023
StartActual
Feb 15, 2023
Primary completionActual
Jul 30, 2023
CompletionActual
Aug 3, 2023
Last update
May 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05739318
Lead sponsor
The First Hospital of Qinhuangdao
Responsible party
Sponsor
First posted
Feb 22, 2023
Start date
Feb 15, 2023
Primary completion
Jul 30, 2023
Completion
Aug 3, 2023
Last update
May 1, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion